LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 80 filers reported holding LYRA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $71,892 | -90.8% | 259,820 | +105.9% | 0.00% | – |
Q1 2024 | $784,840 | +37.2% | 126,180 | +15.6% | 0.00% | – |
Q4 2023 | $572,103 | +53.9% | 109,180 | +14.8% | 0.00% | – |
Q3 2023 | $371,763 | +62.2% | 95,080 | +70.5% | 0.00% | – |
Q2 2023 | $229,256 | +194.7% | 55,780 | +48.4% | 0.00% | – |
Q1 2023 | $77,791 | -67.0% | 37,580 | -50.0% | 0.00% | – |
Q4 2022 | $236,002 | +34.1% | 75,160 | +114.5% | 0.00% | – |
Q3 2022 | $176,000 | -8.8% | 35,043 | +2.3% | 0.00% | – |
Q2 2022 | $193,000 | -82.7% | 34,243 | -64.4% | 0.00% | – |
Q1 2021 | $1,115,000 | +26.0% | 96,246 | +24.0% | 0.00% | – |
Q4 2020 | $885,000 | +73.9% | 77,646 | +70.6% | 0.00% | – |
Q3 2020 | $509,000 | +5.8% | 45,506 | +7.2% | 0.00% | – |
Q2 2020 | $481,000 | – | 42,441 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,777,251 | $10,041,000 | 2.68% |
Perceptive Advisors | 9,146,730 | $51,679,000 | 1.62% |
VR Adviser, LLC | 924,170 | $5,222,000 | 1.03% |
PURA VIDA INVESTMENTS, LLC | 2,576,196 | $14,556,000 | 0.84% |
Nantahala Capital Management | 2,369,668 | $13,389,000 | 0.67% |
Soleus Capital Management, L.P. | 592,417 | $3,347,000 | 0.52% |
Ikarian Capital, LLC | 347,338 | $1,963,000 | 0.36% |
Clearline Capital LP | 119,128 | $673,000 | 0.09% |
CVI Holdings, LLC | 60,822 | $344,000 | 0.02% |
HighMark Wealth Management LLC | 4,000 | $23,000 | 0.02% |